AnodyneWiki

Eletriptan

Eletriptan
Eletriptan
Salts
[]
Eletriptan hydrobromide
Eletriptan hydrobromide
Eletriptan hemisulfate
Eletriptan hemisulfate
Eletriptan succinate
Eletriptan succinate
Eletriptan hydrochloride
Eletriptan hydrochloride
Eletriptan mesylate
Eletriptan mesylate
Molecular structure drawn from PubChem coordinates
Physical properties
[]
Molecular mass382.50 g/mol [1]
SolubilityReadily soluble as hydrobromide formulation [1]
Predicted LogP4.1 [1]
Structural Identifiers
[]
Molecular formulaC22H26N2O2S
IUPAC name5-[2-(benzenesulfonyl)ethyl]-3-[[(2R)-1-methylpyrrolidin-2-yl]methyl]-1H-indole
SMILESCN1CCC[C@@H]1CC2=CNC3=C2C=C(C=C3)CCS(=O)(=O)C4=CC=CC=C4
InChIInChI=1S/C22H26N2O2S/c1-24-12-5-6-19(24)15-18-16-23-22-10-9-17(14-21(18)22)11-13-27(25,26)20-7-3-2-4-8-20/h2-4,7-10,14,16,19,23H,5-6,11-13,15H2,1H3/t19-/m1/s1
InChIKeyPWVXXGRKLHYWKM-LJQANCHMSA-N
CAS number143322-58-1
UNII22QOO9B8KI
PubChem CID77993
Pharmacokinetics[]
Elimination half-life4 hours
MetabolismMainly CYP3A4
Routes of administrationBy mouth

Eletriptan (also known as eletriptanum, Uk 116044, Uk-116044, Uk-116,044, Uk-116044-04 free base, Uk-116,044-04 free base, 5-[2-(benzenesulfonyl)ethyl]-3-{[(2R)-1-methylpyrrolidin-2-yl]methyl}-1H-indole, (R)-3-((1-methyl-2-pyrrolidinyl)methyl)-5-(2-(phenylsulfonyl)ethyl)-1H-indole, 3-(((2R)-1-methylpyrrolidin-2-yl)methyl)-5-(2-phenylsulfonylethyl)-1H-indole or 3-[[(2R)-1-methylpyrrolidin-2-yl]methyl]-5-(2-phenylsulfonylethyl)-1H-indole) is a substance of the α-alkyltryptamine and tryptamine class.

Chemistry

Salts []

Eletriptan is typically found in the form of its hydrobromide, hemisulfate, succinate, hydrochloride and mesylate salts.

 []

Eletriptan is a single defined stereoisomer.

Eletriptan matches Lipinski's rule of five.

Pharmacology

Mechanism of action []

Eletriptan binds with high affinity to 5-HT1B, 5-HT1D and 5-HT1F receptors, has modest affinity for 5-HT1A, 5-HT1E, 5-HT2B and 5-HT7 receptors, and little or no affinity for 5-HT2A, 5-HT2C, 5-HT3, 5-HT4, 5-HT5A and 5-HT6 receptors. In contrast, eletriptan displays insignificant pharmacological activity at adrenergic alpha1, alpha2, or beta; dopaminergic D1 or D2; muscarinic; or opioid receptors. While the full mechanism of action of 5-HT receptor agonists in relieving migrains is not fully elucidated, it is proposed that the activation of 5-HT1 receptors located on intracranial blood vessels leads to vasoconstriction that correlates with the relief of migraine headaches. It is also proposed that the activation of 5-HT1 receptors on sensory nerve endings in the trigeminal system leads to the inhibition of release of pro-inflammatory neuropeptides. [1]

Interactions []

Interaction mechanisms documented in (number of interacting drugs):

induction / metabolism / inhibition68 (4 contraindicated)
shared target7 (6 contraindicated)
shared target6 (6 contraindicated)

Medical side effects []

238 side effects listed on drug labels in (eletriptan).

  • Dizziness
  • Syncope
  • Somnolence
  • Drowsiness
  • Asthenia
  • Fatigue
  • Back pain
  • Hypoaesthesia
  • Numbness
  • Hypertonia
  • Nausea
  • Palpitations
  • Pharyngitis
  • Hyperhidrosis
  • Vertigo
  • Chills
  • Headache
  • Paraesthesia
  • Tingling sensation
  • Dry mouth
  • Abdominal pain
  • Stomach ache
  • Gastrointestinal pain
  • Dysphagia
  • Dyspepsia
  • Flushing
  • Muscle spasms
  • Pain
  • Abdominal pain upper
  • Chest discomfort
  • Discomfort
  • Malaise
  • Throat tightness
  • Feeling hot
  • Decreased appetite
  • Anxiety
  • Arthralgia
  • Musculoskeletal discomfort
  • Myalgia
  • Arthritis
  • Rheumatoid arthritis
  • Asthma
  • Ataxia
  • Confusional state
  • Feeling abnormal
  • Conjunctivitis
  • Constipation
  • Depersonalisation
  • Diarrhoea
  • Dysgeusia
  • Dyspnoea
  • Ear pain
  • Oedema
  • Eructation
  • Oesophagitis
  • Dermatitis
  • Rash
  • Flatulence
  • Gastritis
  • Gastrointestinal disorder
  • Glossitis
  • Hyperaesthesia
  • Hyperpathia
  • Hypertension
  • Lacrimal disorder
  • Lacrimal structural disorder
  • Nervousness
  • Tension
  • Polyuria
  • Urine output increased
  • Pruritus
  • Respiratory tract infection
  • Rhinitis
  • Salivary hypersecretion
  • Skin disorder
  • Unspecified disorder of skin and subcutaneous tissue
  • Speech disorder
  • Tachycardia
  • Thirst
  • Tinnitus
  • Tremor
  • Pollakiuria
  • Urethral disorder
  • Urinary tract disorder
  • Yawning
  • Peripheral vascular disorder
  • Stupor
  • Depressed level of consciousness
  • Agitation
  • Hyperkinesia
  • Apathy
  • Flat affect
  • Mood swings
  • Affect lability
  • Photophobia
  • Oedema peripheral
  • Migraine
  • Blood creatine phosphokinase increased
  • Liver function test abnormal
  • Bone pain
  • Eye pain
  • Ill-defined disorder
  • Thinking abnormal
  • Mental disability
  • Abnormal dreams
  • Euphoric mood
  • Erectile dysfunction
  • Coordination abnormal
  • Face oedema
  • Insomnia
  • Muscular weakness
  • Visual impairment
  • Abscess
  • Alopecia
  • Amnesia
  • Anaemia
  • Angina pectoris
  • Aphasia
  • Arrhythmia
  • Atrial fibrillation
  • Atrioventricular block
  • Bone neoplasm
  • Bronchitis
  • Candida infection
  • Cerebrovascular disorder
  • Cyanosis
  • Dermatitis exfoliative
  • Diplopia
  • Ear disorder
  • Eczema
  • Epistaxis
  • Eye haemorrhage
  • Body temperature increased
  • Gingivitis
  • Goitre
  • Breath odour
  • Hallucination
  • Haematemesis
  • Hemiplegia
  • Hernia
  • Hiccups
  • Hyperbilirubinaemia
  • Hyperglycaemia
  • Hypersensitivity
  • Hyperventilation
  • Hypotension
  • Body temperature decreased
  • Hypothermia
  • Conversion disorder
  • Influenza
  • Arthropathy
  • Osteoarthritis
  • Laryngitis
  • Leukopenia
  • Vaginal discharge
  • Breast pain
  • Menorrhagia
  • Menstrual disorder
  • Myopathy
  • Neurosis
  • Otitis media
  • Psoriasis
  • Purpura
  • Vascular purpura
  • Anorectal disorder
  • Convulsion
  • Shock
  • Sinusitis
  • Stomatitis
  • Loss of consciousness
  • Tenosynovitis
  • Thrombophlebitis
  • Thyroiditis
  • Tongue disorder
  • Tongue oedema
  • Tooth disorder
  • Urticaria
  • Vaginal inflammation
  • Vaginal infection
  • Vomiting
  • Weight increased
  • Weight decreased
  • Ventricular arrhythmia
  • Vasospasm
  • Oculogyric crisis
  • Monocytosis
  • Hypokinesia
  • Thyroid adenoma
  • Skin hypertrophy
  • Injury
  • Mania
  • Blood alkaline phosphatase increased
  • Skin discolouration
  • Dry skin
  • Accommodation disorder
  • Muscle twitching
  • Increased appetite
  • Sputum increased
  • Increased bronchial secretion
  • Major depression
  • Dry eye
  • Abdominal distension
  • Rash maculo-papular
  • Bradycardia
  • Laboratory test abnormal
  • Neuropathy peripheral
  • Lymphadenopathy
  • Dementia
  • Paralysis
  • Choking sensation
  • Renal pain
  • Cough
  • Gait disturbance
  • Sleep disorder
  • Parosmia
  • Catatonia
  • Prinzmetal angina
  • Angioedema
  • Arteriospasm coronary
  • Hypertensive crisis
  • Immune system disorder
  • Muscle atrophy
  • Myocardial infarction
  • Acute coronary syndrome
  • Nervous system disorder
  • Sensory loss
  • Ventricular fibrillation
  • Ventricular tachycardia
  • Viral infection
  • Burning sensation
  • Myocardial ischaemia
  • Colitis ischaemic
  • Abdominal discomfort
  • Gastrointestinal discomfort
  • Pain in jaw
  • Blood pressure increased
  • Serotonin syndrome
  • Medication overuse headache

Indications

  • Aura
  • Basilar migraine
  • Cluster headache
  • Hypertension
  • Migraine
  • Uncontrolled hypertension

 []

  • Australia: Eletriptan is a S3 & S4.
  • Canada: Eletriptan is Prescription only.
  • United Kingdom: Eletriptan is Prescription only.[3]
  • United States: Eletriptan is Prescription only.[4]
  • Other: Eletriptan is a Rx-only.

See also []

External links []

References []

  1. National Center for Biotechnology Information. PubChem Compound Summary for CID 77993, Eletriptan. Accessed November 20, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/77993
  2. U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Eletriptan. UNII: 22QOO9B8KI. Global Substance Registration System. Accessed November 20, 2026. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/22QOO9B8KI
  3. Relpax 20mg Film-Coated Tablets. - Summary of Product Characteristics (SmPC). (emc). 3 July 2020. https://www.medicines.org.uk/emc/product/1568/smpc
  4. Relpax- eletriptan hydrobromide tablet, film coated. DailyMed. 10 December 2019. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=986dc112-b97b-44a3-bfaf-074f906f8bb2

Data sources []

SourceStatusUpdated (UTC)
dosingmissing (no dosing statistics)2026-11-20 09:10:00
drugspromissing (no DrugsPRO reagent data)2026-11-20 09:09:56
erowidmissing (no Erowid substance of that name)2026-11-20 09:09:56
gsrsok2026-11-20 09:10:00
hmdbmissing (hmdb.ca refused automated access to HMDB0014361)2026-11-20 09:09:56
keggok2026-11-20 09:09:58
pubchemok2026-11-20 09:09:56
redditmissing (no r/tripreports posts mention it)2026-11-20 09:09:56
siderok2026-11-20 09:09:56
structureok2026-11-20 09:09:56
wikipediaok2026-11-20 09:09:57